Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
11.6%
% of XPH's 43 holdings also in IBRN
11.6%
% of IBRN's 57 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
INTRA-CELLULAR THERAPIES INC | 3.9% | 4.2% | 3.9% |
|
LONGBOARD PHARMACEUTICALS, INC. | 4.2% | 3.7% | 3.7% |
|
EDGEWISE THERAPEUTICS, INC. | 3.4% | 3.4% | 3.4% |
|
SUPERNUS PHARMACEUTICALS INC | 2.2% | 3.4% | 2.2% |
|
CASSAVA SCIENCES, INC. | 2.7% | 2.1% | 2.1% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to IBRN
|
CORCEPT THERAPEUTICS INC | 4.8% |
|
BRISTOL-MYERS SQUIBB CO | 4.1% |
 |
JAZZ PHARMACEUTICALS PLC | 4.0% |
|
VIATRIS, INC. | 3.9% |
|
AXSOME THERAPEUTICS, INC. | 3.5% |
|
CATALENT INC | 3.5% |
|
ELANCO ANIMAL HEALTH, INC. | 3.4% |
|
PERRIGO CO | 3.4% |
|
JOHNSON & JOHNSON | 3.3% |
|
ROYALTY PHARMA PLC CLASS A | 3.3% |
XPH Underweight Relative to IBRN
|
PTC THERAPEUTICS INC | -4.6% |
|
ALKERMES PLC | -3.9% |
|
ACADIA PHARMACEUTICALS INC | -3.9% |
 |
ARGENX SE ADR | -3.9% |
|
CATALYST PHARMACEUTICAL PART | -3.9% |
|
AXONICS MODULATION TECHNOLOGIES, INC | -3.8% |
|
NEUROCRINE BIOSCIENCES INC | -3.6% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.5% |
|
DYNE THERAPEUTICS INC | -3.2% |
|
SCHOLAR ROCK HOLDING CORP. | -3.2% |